(Q34841849)

4 August 2017

3 references

27 November 2019

13 December 2019

25 November 2020

Diagnosis and management of antibody-mediated rejection: current status and novel approaches (English)

1 reference

4 August 2017

1 reference

27 November 2019

1 reference

13 December 2019

1 reference

organ transplantation

1 reference

25 November 2020

2

D B Kaufman

1 reference

4 August 2017

A Djamali

1

1 reference

4 August 2017

T M Ellis

3

1 reference

4 August 2017

W Zhong

4

1 reference

4 August 2017

A Matas

5

1 reference

4 August 2017

M Samaniego

6

1 reference

4 August 2017

language of work or name

English

0 references

publication date

8 January 2014

1 reference

American Journal of Transplantation

4 August 2017

1 February 2014

3 references

27 November 2019

13 December 2019

25 November 2020

4 references

4 August 2017

27 November 2019

13 December 2019

25 November 2020

14

1 reference

4 August 2017

255-271

1 reference

4 August 2017

2

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

4 August 2017

3 references

27 November 2019

13 December 2019

Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig

25 November 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Cryptic B cell response to renal transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Molecular diagnosis of antibody-mediated rejection in human kidney transplants

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Rituximab in renal transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Endothelial injury in renal antibody-mediated allograft rejection: a schematic view based on pathogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

The paradoxical functions of B cells and antibodies in transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Donor-specific antibodies adversely affect kidney allograft outcomes.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

New approaches for detecting complement-fixing antibodies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Prevention of antibody-mediated kidney transplant rejection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Antibody-mediated rejection in kidney transplantation: a review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Diagnostic challenges in chronic antibody-mediated rejection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naïve B cells.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Banff 2011 Meeting report: new concepts in antibody-mediated rejection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Pros and cons for C4d as a biomarker

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Revisiting traditional risk factors for rejection and graft loss after kidney transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Targeting B cells and antibody in transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Alemtuzumab induction in renal transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Summary of FDA antibody-mediated rejection workshop

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Role of proteasome inhibition in sensitized transplant candidates.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Antibody-mediated rejection in kidney transplantation: an update

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Natural killer cells in rejection and tolerance of solid organ allografts

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Long-term renal allograft survival in the United States: a critical reappraisal

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

An integrated view of molecular changes, histopathology and outcomes in kidney transplants

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

The evolution and clinical impact of human leukocyte antigen technology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

KDIGO clinical practice guideline for the care of kidney transplant recipients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Effect of antibodies on endothelium

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Utility of the virtual crossmatch in solid organ transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

BAFF is increased in renal transplant patients following treatment with alemtuzumab

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Medical care of kidney transplant recipients after the first posttransplant year

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Presensitization: the problem and its management

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Immunosuppressive drugs for kidney transplantation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Improved generation of HLA class I/peptide tetramers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Anti-HLA antibodies after solid organ transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Analysis of MHC class II presentation of particulate antigens of B lymphocytes.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Serotyping for homotransplantation. XII. Occurrence of cytotoxic antibodies following kidney transplantation in man.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Plasma exchange in acute renal transplant rejection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Lessons from cyclosporine monotherapy in renal transplantation: the impact of acute rejection on long-term allograft outcome

8 July 2018

1 reference

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

21 January 2018

1 reference

A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.

21 January 2018

1 reference

Identifying specific causes of kidney allograft loss.

21 January 2018

1 reference

Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.

21 January 2018

1 reference

NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.

21 January 2018

1 reference

Banff 2003 meeting report: new diagnostic insights and standards.

21 January 2018

1 reference

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions

21 January 2018

1 reference

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure

21 January 2018

1 reference

Mastering the risk of HLA antibodies in kidney transplantation: an algorithm based on pretransplant single-antigen flow bead techniques.

21 January 2018

1 reference

Luminex-based desensitization protocols: the University of Wisconsin initial experience.

21 January 2018

1 reference

Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure.

21 January 2018

1 reference

Five-year outcomes in living donor kidney transplants with a positive crossmatch.

21 January 2018

1 reference

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation

21 January 2018

1 reference

Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.

21 January 2018

1 reference

Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection

21 January 2018

1 reference

Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy.

21 January 2018

1 reference

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

21 January 2018

1 reference

A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.

21 January 2018

1 reference

The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes

21 January 2018

1 reference

C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation.

21 January 2018

1 reference

A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation

21 January 2018

1 reference

Rituximab and intravenous immune globulin for desensitization during renal transplantation

21 January 2018

1 reference

Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients.

21 January 2018

1 reference

Desensitization in HLA-incompatible kidney recipients and survival.

21 January 2018

1 reference

Positive cross-match living donor kidney transplantation: longer-term outcomes

21 January 2018

1 reference

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

21 January 2018

1 reference

In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.

21 January 2018

1 reference

Chain transplantation: initial experience of a large multicenter program.

21 January 2018

1 reference

Kidney paired donation and optimizing the use of live donor organs.

21 January 2018

1 reference

Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.

21 January 2018

1 reference

Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.

21 January 2018

1 reference

Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.

21 January 2018

1 reference

Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.

21 January 2018

1 reference

Impact of rituximab therapy for treatment of acute humoral rejection

21 January 2018

1 reference

Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring.

21 January 2018

1 reference

Bortezomib: a new player in pre- and post-transplant desensitization?

21 January 2018

1 reference

Antibody-Mediated Rejection After Alemtuzumab Induction: Incidence, Risk Factors, and Predictors of Poor Outcome

21 January 2018

1 reference

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285166

Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys

9 December 2018

1 reference

12 December 2020

The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome

1 reference

12 December 2020

Plasma exchange in the treatment of vascular rejection. Relationship between histological changes and therapeutic response

1 reference

12 December 2020

Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies

1 reference

12 December 2020

Value of plasma exchange in renal transplant rejection induced by specific anti-HLA antibodies

1 reference

12 December 2020

Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss

1 reference

12 December 2020

Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients

1 reference

12 December 2020

Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts

1 reference

12 December 2020

Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes

1 reference

12 December 2020

Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies

1 reference

12 December 2020

Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection

1 reference

12 December 2020

Capillary deposition of C4d complement fragment and early renal graft loss

1 reference

12 December 2020

Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients

1 reference

12 December 2020

A controlled trial of plasmapheresis in the treatment of renal allograft rejection

1 reference

12 December 2020

Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?

1 reference

12 December 2020

Alemtuzumab induction therapy in highly sensitized kidney transplant recipients

1 reference

12 December 2020

Targeted monitoring of donor-specific HLA antibodies following renal transplantation

1 reference

12 December 2020

Pretransplant Donor-Specific HLA Class-I and -II Antibodies Are Associated With an Increased Risk for Kidney Graft Failure

1 reference

12 December 2020

Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial

1 reference

12 December 2020

Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation

1 reference

12 December 2020

Effects of plasmapheresis in renal transplant rejection. A controlled study

1 reference

12 December 2020

The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection

1 reference

12 December 2020

Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab

1 reference

12 December 2020

Limitations of rituximab/IVIg desensitization protocol in kidney transplantation; is this better than a tincture of time?

1 reference

12 December 2020

Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)

1 reference

12 December 2020

Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients

1 reference

12 December 2020

Successful expansion of the living donor pool by alternative living donation programs

1 reference

12 December 2020

C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation

1 reference

12 December 2020

De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure

1 reference

12 December 2020

Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period

1 reference

12 December 2020

Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts

1 reference

12 December 2020

The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody

1 reference

12 December 2020

Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries

1 reference

12 December 2020

Plasma exchange in acute renal allograft rejection. A controlled trial

1 reference

12 December 2020

Antibodies against MICA antigens and kidney-transplant rejection

1 reference

12 December 2020

Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence

1 reference

12 December 2020

Improved graft survival after renal transplantation in the United States, 1988 to 1996

1 reference

12 December 2020

Durability of antibody removal following proteasome inhibitor-based therapy

1 reference

12 December 2020

Identifiers

DOI

10.1111/AJT.12589

1 reference

4 August 2017

1 reference

4 August 2017

1 reference